Full Text
Economic Evaluation Of Omalizumab Add-On Therapy In Patients With Uncontrolled Severe Allergic Asthma From The Private Health Care System Perspective In Brazil

Abstract

Authors

C. Suzuki N.B. Santoni N.L. Silva

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×